Category Archives: Parkinson’s Treatment

THOMASVILLE Staff report Have you noticed a slight shaking ortremorin your finger, thumb, hand, chin or lip? Does your leg shake when you sit down or relax? Twitching or shaking of limbs is a common early sign of Parkinsons disease, a progressive, chronic disorder of the nervous system. Other symptoms include loss of smell, sudden movements while sleeping and persistent stiffness or pain in shoulders, hips, arms and legs. Approximately 60,000 Americans are diagnosed with Parkinson's disease each year, and men are one and a half times more likely to develop the disease than women. While incidence of Parkinsons increases with age, its estimated four percent of people are diagnosed before the age of 50. As part of Archbold Memorial Hospitals continuing Health Talk free community lecture series, neurologist Michael Price, MD, will present, Parkinsons Disease: Signs, Symptoms, Prevention and Treatment, on Tuesday, June 18. The talk is offered free as a clinical outreach effort to uphold Archbolds core value of Community Benefit. Price will discuss causes and early symptoms associated with the disease, as well as medication, treatment options and prevention for those at risk and patients who have been diagnosed with the disease. Price is board certified in … Continue reading →

By Brian Ballou and John R. Ellement, Globe Staff QUINCY The Milton High School track coach accused of kissing a 16-year-old member of his track team is being treated for Parkinsons disease, and that treatment has increased his libido and decreased his impulse control, his defense attorney said today. Dale Snyder pleaded not guilty in Quincy District Court to one count of indecent assault and battery and two counts of assault and battery before Judge Mark Coven, who set bail for the 64-year-old Abington resident at $10,000 cash. Defense attorney Thomas Lawton told Coven that a key issue in the case is how Snyder, a married man with a teenaged child, had changed since he was diagnosed with Parkinsons about two years ago. Those changes have intensified while he receives a drug that Lawton identified as Stalevo. Lawton told Coven that Snyders impulse control has been weakened since the diagnosis and the treatment began. At the same time, Snyders libido has increased, the attorney said. Snyder, who is scheduled to retire June 24 after 27 years in the Milton public schools, is accused of indecently assaulting the unidentified girl on June 2 while in his office at Milton High School. … Continue reading →

Sydney (PRWEB) June 07, 2013 The worlds leading experts in Parkinsons disease and Movement Disorders will present the latest research findings and state-of-the-art treatment options at The Movement Disorder Societys 17th International Congress of Parkinsons Disease and Movement Disorders in Sydney, June 16-20, 2013. The 17th International Congress, held at the Sydney Convention and Exhibition Centre, will be attended by over 2,100 international physicians, researchers and other healthcare professionals. Attendees will be able to view over 1,300 scientific abstracts submitted by clinicians from around the world. The International Congress Scientific Program consists of Plenary, Parallel, and Video Sessions, as well as Skills Workshops, Teaching Courses, and Guided Poster Tours. Registration Members of the media receive complimentary full-access registration to the Congress. For information on how to register, please contact Elizabeth Clausen at eclausen(at)movementdisorders(dot)org. News Releases Read summaries of newsworthy research to be presented at the Congress. -New findings on the lessebo effect in Parkinson's disease may be game-changer for study design -Apomorphine represents possible therapeutic target to reduce Parkinson's disease dementia -New MDS Study Groups bring researchers together to focus on MDS mission-driven initiatives -New mouse model provides insight into human -synuclein accumulation in Parkinson's disease -Increased risk of malignant … Continue reading →

VIDEO | Trillanes on JPE exit speech: Nothing but 'rants from a bitter man' 05-Jun-13, 9:00 PM | InterAksyon.com and News5 Senator Antonio Trillanes IV was caught on cam seemingly smirking while Senate president Juan Ponce Enrile was reading his resignation speech on Wednesday. The young lawmaker dismissed Enrile's speech as nothing but "rants from a bitter man." Worker rights issues pose a challenge to Gulf building boom 05-Jun-13, 11:13 PM | Praveen Menon, Reuters A strike by thousands of migrant workers at Dubai's biggest builder Arabtec last month may be a harbinger of a new wave of industrial activism that threatens to disrupt the Gulf's latest construction boom. VIDEO | Python in Mandaluyong swallows then coughs up dog 05-Jun-13, 4:20 PM | Benjie Dorango, News5 A group of men having a drunken spree in Mandaluyong City Tuesday night sobered up when they saw a python in Barangay Daang Bakal cough up a black dog. Serendra blast probe report could be out Friday - Palace 05-Jun-13, 5:29 PM | Philippine News Agency Malacanang said the results of the investigation on the explosion at the Serendra-2 condominium in Taguig City could be out by Friday. BFAR imposes shellfish ban on Eastern … Continue reading →

Public release date: 4-Jun-2013 [ | E-mail | Share ] Contact: Fiona Godwin fgodwin@plos.org 01-223-442-834 Public Library of Science Increased iron levels may be causally associated with a decreased risk of developing Parkinson's disease, says a new paper published this week in PLOS Medicine. Irene Pichler from EURAC in Italy and a group of international colleagues investigated whether there was any evidence of an association between serum iron levels and the risk of Parkinson's disease. While the causes of Parkinson's disease are currently unknown, a combination of genetic and environmental factors are said to be attributed to the disease. Because previous studies have shown a possible association between lower blood levels of iron in people with Parkinson's disease compared with controls, the researchers used a Mendelian randomization approach to investigate this link. The researchers estimated the effect of blood iron levels on the risk of Parkinsons disease using three polymorphisms in two genes, HFE and TMPRSS6. For each polymorphism, they performed a meta-analysis combining the results of studies investigating the genetic effect on iron levels, which included almost 22,000 people from Europe and Australia, and a meta-analysis of studies investigating the genetic effect on the risk of Parkinsons disease, which … Continue reading →

By Brandy Betz - June 3, 2013 | Tickers: ACAD, AGN | 0 Comments Brandy is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited. Acadia Pharmaceuticals (NASDAQ: ACAD) had a busy couple of months. The new member of the Nasdaq Biotechnology Index recently completed a $150 million public offering to help push lead drug candidate pimavanserin, a treatment for Parkinsons disease psychosis, or PDP. In April, Acadia shares soared over 50% when the company filed an accelerated new drug application for pimavanserin after talks with the Food and Drug Administration. The pipelines scant but includes areas of unmet need and an Allergan (NYSE: AGN) partnership. Whats next for Acadia? Here are three things to know about Acadias future. 1. Lead Drug Pimavanserins accelerated filing pertains to PDP, but the companys pursuing mid-stage trials for additional indications that include Alzheimers disease psychosis, or ADP. Parkinsons disease has no cure but the symptom treatments work by increasing the brains supply of dopamine. Pimavanserin is non-dopaminergic -- meaning, it doesnt impact dopamine levels and thus wont interfere with primary treatment. Acadia estimates that PDP occurs in up to 60% … Continue reading →

NESS ZIONA, Israel, June 3, 2013 /PRNewswire/ -- NeuroDerm, Ltd. was informed today that it was awarded, for the second time, a grant of $1M by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to support the clinical development of its subcutaneously delivered drug for the treatment of Parkinson's disease. These funds, part of the Foundation's 2013 Therapeutic Pipeline program, will support an upcoming phase 2 clinical trial with ND0612, a novel drug for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula under development for continuous administration through a sub-cutaneous delivery patch that would maintain constant levodopa plasma concentrations. ND0612 has so far been shown in human trials to be safe and tolerable and, for the first time in man, to maintain steady state, clinically meaningful levodopa plasma concentrations. ND0612 can be administered subcutaneously in a convenient manner and has the potential to significantly improve the current standard of treatment of Parkinson's disease patients. "ND0612's potential ability to provide steady, therapeutic levodopa levels could improve upon current symptomatic treatments for Parkinson's patients," said Todd Sherer, PhD, CEO of MJFF. "Finding such a drug remains a priority for the Foundation" "We thank The Michael J. Fox … Continue reading →

Parkinson's Disease Treatment: Balance and Walking (Gait) Improve TMJ Connection Part 2 At two and a half month follow up visit with Dr. Demerjian wearing his TMJ mouthpiece. No more jaw joint clicking, dizziness, ringing in his ears, neck pain ... By: Gary Demerjian … Continue reading →

On their journey to increase awareness about Parkinsons disease, Roy and Lynn Roden found a happier, simpler life. It was the trip of a lifetime and a trip that changed their lives. Roy and Lynn Roden rode their bicycles cross-country on a fourmonth, 5,000-mile journey from Seattle to Miami to raise awareness about Parkinsons disease and money to find a cure. Roy, 55, who grew up in Pembroke Pines and Miami, was diagnosed with Parkinsons disease five years ago. Hes worked in the fitness industry for more than 37 years. He met his wife Lynn, who is now a personal trainer, when she was a client at Olympia Gym in Aventura.The Rodens are certainly not ones to sit around and let Parkinsons disease take control. The couple began their Parkinsons Ride Across America last November with their two dogs in tow, riding in carriers behind them. Their route took them along the Pacific Coast Highway in California and then through Arizona, New Mexico, Texas, Louisiana, Mississippi, Alabama and finally, to Florida. The Rodens return home was a brief pit stop on their continuing journey. They were back in the area just long enough to pack up their Airstream with lifes … Continue reading →

Scottsdale, AZ (PRWEB) May 29, 2013 The Bob & Renee Parsons Foundation has contributed $1 million to the Muhammad Ali Parkinson Center at Barrow Neurological Institute. The gift will support two fellowships in Parkinsons disease plus additional staffing for the Center and research in the Gait and Balance Laboratory. Bob and Renee Parsons are long-time supporters of the Muhammad Ali Parkinson Center. The million dollar grant will fund clinical development programs, emphasizing care for complex and often life-threatening movement disorders. Approximately 60,000 Americans are diagnosed with Parkinsons disease each year according to the Parkinsons Disease Foundation. Education and on-going research are crucial to solving the mysteries of the intractable disease and making a difference in the lives of those who are afflicted. Knowing that you are going to receive the best possible care from a kick-ass doctor is half the battle, said Bob Parsons. Renee and I hope that our gift will make a positive difference in the lives of Arizonans by positioning funds to attract the countrys best and brightest to the Valley. Fellowships are critical to our mission of training the next generation of movement disorders specialists, says Abraham Lieberman, MD, director of the Muhammad Ali Parkinson Center. … Continue reading →